{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T11:10:22Z","timestamp":1772277022515,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1053\/j.seminoncol.2014.12.020","type":"journal-article","created":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T02:55:15Z","timestamp":1421117715000},"page":"e13-e24","source":"Crossref","is-referenced-by-count":15,"title":["Synchronous Primary Carcinoma of Breast and Ovary Versus Ovarian Metastases"],"prefix":"10.1053","volume":"42","author":[{"given":"Budhi S.","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler P.","family":"Robin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Sams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anothony D.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Kaklamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kelly Marcom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2014.12.020_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib2","unstructured":"National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology. breast cancer, version 3.2014. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed 5\/15\/14."},{"key":"10.1053\/j.seminoncol.2014.12.020_bib3","unstructured":"National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology. ovarian cancer, version 3.2014. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf. Accessed 5\/15\/14."},{"key":"10.1053\/j.seminoncol.2014.12.020_bib4","unstructured":"Lindor NM, Friedman S, Guidugli L, et al. Progress in clinical interpretation of DNA variants of undetermined significance in BRCA1\/2. Based on a publication titled \"A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).\" 222.mayo.edu\/research\/document\/brca-riskpdf\/doc-10026644."},{"key":"10.1053\/j.seminoncol.2014.12.020_bib5","doi-asserted-by":"crossref","unstructured":"Morris G. Assessing genetic variants of undetermined significance: the example of breast cancer. 2013. www.els.net\/WileyCDA\/EIsArticle\/refld-a0025220.html.","DOI":"10.1002\/9780470015902.a0025220"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.12.020_bib6","first-page":"449","article-title":"Ovarian disease in women with breast cancer","volume":"84","author":"Curtin","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.12.020_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.AOG.0000154162.51442.14","article-title":"Ovarian malignancy in breast cancer patients with an adnexal mass","volume":"105","author":"Simpkins","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.12.020_bib8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cncr.24807","article-title":"Ovarian metastases from breast cancer: report of 29 cases","volume":"116","author":"Bigorie","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.020_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/bjc.1984.135","article-title":"A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast","volume":"50","author":"Harris","year":"1984","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.020_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jso.2930480106","article-title":"Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study","volume":"48","author":"Lamovec","year":"1991","journal-title":"J Surg Oncol"},{"issue":"11","key":"10.1053\/j.seminoncol.2014.12.020_bib11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","article-title":"Trends in incidence rates of invasive lobular and ductal breast carcinoma","volume":"289","author":"Li","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.12.020_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.breast.2010.02.007","article-title":"Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors","volume":"19","author":"Chia","year":"2010","journal-title":"Breast"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.020_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1053\/j.seminoncol.2014.12.020_bib14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.humpath.2012.10.009","article-title":"Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas","volume":"44","author":"Luo","year":"2013","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.020_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.12.020_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/PAP.0b013e3182a28a68","article-title":"Value of GATA3 immunostaining in tumor diagnosis: a review","volume":"20","author":"Ordonez","year":"2013","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.12.020_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncy.21393","article-title":"GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens","volume":"122","author":"Shield","year":"2014","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.020_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/TDP92PQLDE2HLEET","article-title":"Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity","volume":"127","author":"Bhargava","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1053\/j.seminoncol.2014.12.020_bib19","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.pas.0000176429.88702.36","article-title":"Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary","volume":"29","author":"Tornos","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.12.020_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0046-8177(89)90137-8","article-title":"Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin","volume":"20","author":"Wick","year":"1989","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.12.020_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2559.2005.02194.x","article-title":"Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features","volume":"47","author":"McCluggage","year":"2005","journal-title":"Histopathology"},{"issue":"12","key":"10.1053\/j.seminoncol.2014.12.020_bib22","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/PAS.0b013e31822d787c","article-title":"PAX2 and PAX8 expression in primary and metastatic mullerian epithelial tumors: a comprehensive comparison","volume":"35","author":"Ozcan","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1053\/j.seminoncol.2014.12.020_bib23","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.5858\/2007-131-1561-POIMHD","article-title":"Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma","volume":"131","author":"Park","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.12.020_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAP.0b013e3180504abf","article-title":"From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II","volume":"14","author":"Young","year":"2007","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.12.020_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2013.10.004","article-title":"A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases","volume":"50","author":"Aurilio","year":"2014","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.12.020_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2005.05.028","article-title":"The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries","volume":"98","author":"Ayhan","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.12.020_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0090-8258(03)00275-0","article-title":"Breast cancer metastatic to abdomen and pelvis: role of surgical resection","volume":"90","author":"Eitan","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.020_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/gyno.1995.1278","article-title":"Clinical implications of metastases to the ovary","volume":"59","author":"Fujiwara","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/030089160609200605","article-title":"Analysis of metastatic ovarian tumors from extragenital primary sites","volume":"92","author":"Turan","year":"2006","journal-title":"Tumori"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib30","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/1097-0142(19890815)64:4<892::AID-CNCR2820640422>3.0.CO;2-C","article-title":"Ovarian metastases of breast carcinoma. A clinicopathologic study of 59 cases","volume":"64","author":"Gagnon","year":"1989","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib31","first-page":"637","article-title":"Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast","volume":"114","author":"Borst","year":"1993","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1023\/A:1008239124657","article-title":"Synchronous inflammatory breast cancer and advanced ovarian carcinoma: a case with prolonged disease-free survival","volume":"10","author":"Sandor","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000121003","article-title":"Occurrence of synchronous invasive lobular breast carcinoma and poorly differentiated ovarian carcinoma in a single peritoneal deposit","volume":"73","author":"Syed","year":"2007","journal-title":"Oncology"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01807033","article-title":"Age at diagnosis and multiple primary cancers of the breast and ovary","volume":"41","author":"Suris-Swartz","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib35","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/00000478-200412000-00015","article-title":"Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall","volume":"28","author":"Recine","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.020_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1200\/JCO.2014.57.0572","article-title":"Impact of the addition of carboplatin and\/or bevacizumab to neo-adjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide: CALGB (Alliance)","volume":"33","author":"Sikov","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1200\/JCO.2009.22.4725","article-title":"Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer","volume":"28","author":"Silver","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib38","doi-asserted-by":"crossref","unstructured":"von Minckwitz G, Schneeweiss A, Loibl S, et al. Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial. Lancet Oncol. 2014;15(7):747\u201356.","DOI":"10.1016\/S1470-2045(14)70160-3"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib39","first-page":"551","article-title":"\u2018BRCAness\u2019 and its implications for platinum action in gynecologic cancer","volume":"34","author":"Muggia","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib40","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.2001.19.3.881","article-title":"Aromatase inhibitors in the treatment and prevention of breast cancer","volume":"19","author":"Goss","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/13547500903312173","article-title":"Increased HER2\/neu expression in recurrent hormone receptor-positive breast cancer","volume":"15","author":"Kaklamani","year":"2010","journal-title":"Biomarkers"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib43","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12032-013-0798-y","article-title":"Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis","volume":"31","author":"Yao","year":"2014","journal-title":"Med Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib44","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.hoc.2013.05.004","article-title":"Endocrine therapy for advanced\/metastatic breast cancer","volume":"27","author":"Schiavon","year":"2013","journal-title":"Hematol.Oncol.Clin.North Am"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib45","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2013.51.4489","article-title":"Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial","volume":"32","author":"Pujade-Lauraine","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib46","doi-asserted-by":"crossref","first-page":"e81858","DOI":"10.1371\/journal.pone.0081858","article-title":"Phase III trials of standard chemotherapy with or without bevacizumab for ovarian cancer: a meta-analysis","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS.One"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7150\/jca.1.27","article-title":"Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review","author":"Klein","year":"2010","journal-title":"J Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib48","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ygyno.2006.01.056","article-title":"Ovarian cancer metastatic to the breast","volume":"102","author":"Micha","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/172460089801300402","article-title":"CA 125: the past and the future","volume":"13","author":"Bast","year":"1998","journal-title":"Int J Biol Markers"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib50","unstructured":"Ca Gene Website. 2014. https:\/\/www4.utsouthwestern.edu\/breasthealth\/cagene\/."},{"key":"10.1053\/j.seminoncol.2014.12.020_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10549-012-2158-6","article-title":"Systemic therapy options in BRCA mutation-associated breast cancer","volume":"135","author":"Bayraktar","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jso.2930480106","article-title":"Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study","volume":"48","author":"Lamovec","year":"1991","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.12.020_bib53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5468\/ogs.2013.56.5.341","article-title":"Ovarian metastasis from pulmonary adenocarcinoma","volume":"56","author":"Jung","year":"2013","journal-title":"Obstet Gynecol Sci"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00000478-199302000-00011","article-title":"Ovarian carcinoma metastasis to the breast case report and review of the literature","volume":"17","author":"Yamasaki","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib55","first-page":"152","article-title":"Serous cystadenocarcinoma of the ovary with simultaneous breast metastases","volume":"90","author":"Manini","year":"1998","journal-title":"Description of a case. Pathologica"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib56","first-page":"189","article-title":"Ovarian carcinoma metastatic to bilateral axillary lymph nodes. A case report","volume":"20","author":"Orris","year":"1999","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib57","first-page":"16","article-title":"Inflammatory breast metastasis from primary ovarian cancer: case report","volume":"20","author":"Fondrinier","year":"1999","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib58","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1034\/j.1600-0412.1999.780918.x","article-title":"Metastasis to the breast from an ovarian carcinoma","volume":"78","author":"Petersen","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib59","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/clon.1999.9097","article-title":"Ovarian carcinoma metastatic to the breast","volume":"11","author":"Wadhwa","year":"1999","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000052946","article-title":"Ovarian carcinoma metastatic to the breast","volume":"52","author":"Cormio","year":"2001","journal-title":"Gynecol Obstet Invest"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib61","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1006\/gyno.2001.6402","article-title":"Inflammatory breast metastases of ovarian cancer: a case report","volume":"83","author":"Kayikcioglu","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib62","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/1097-0142(197206)29:6<1691::AID-CNCR2820290637>3.0.CO;2-4","article-title":"Cancers metastatic to the breast","volume":"29","author":"Hajdu","year":"1972","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7","article-title":"Metastases in carcinoma: analysis of 1000 autopsied cases","volume":"3","author":"Abrams","year":"1950","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/bjs.18004720111","article-title":"Metastatic tumors in the breast","volume":"47","author":"Sandison","year":"1959","journal-title":"Br J Surg"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib65","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0707056","article-title":"Weekly paclitaxel in the adjuvant treatment of breast cancer","volume":"358","author":"Sparano","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib66","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib67","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1200\/JCO.2006.05.7406","article-title":"Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography","volume":"24","author":"Rousseau","year":"2006","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1053\/j.seminoncol.2014.12.020_bib68","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00259-007-0459-5","article-title":"[18F] FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy","volume":"34","author":"Berriolo-Riedinger","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib69","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1148\/radiol.2392021099","article-title":"Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results","volume":"239","author":"Padhani","year":"2006","journal-title":"Radiology"},{"issue":"35","key":"10.1053\/j.seminoncol.2014.12.020_bib70","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1200\/JCO.2007.14.6134","article-title":"Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib71","first-page":"e37","article-title":"Optimizing chemotherapy in triple-negative breast cancer: the role of platinum","author":"Telli","year":"2014","journal-title":"ASCO Educational Book"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.12.020_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4143\/crt.2008.40.4.207","article-title":"Breast cancer metastasis to the stomach resembling early gastric cancer","volume":"40","author":"Eo","year":"2008","journal-title":"Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2014.12.020_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7819-5-75","article-title":"Breast cancer metastasis to the stomach may mimic primary gastric cancer: report of two cases and review of the literature","volume":"5","author":"Jones","year":"2007","journal-title":"World J Surg Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775414002917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775414002917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T17:26:21Z","timestamp":1650993981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775414002917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0093775414002917"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2014.12.020","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}